Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-γ-dependent IL-10 reactivation

被引:87
作者
Shaw, Michael H.
Freeman, Gordon J.
Scott, Mark F.
Fox, Barbara A.
Bzik, David J.
Belkaid, Yasmine
Yap, George S.
机构
[1] Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[3] Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA
[4] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.176.12.7263
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Jak, Tyk2, is activated in response to IL-12 and IFN-alpha beta and promotes IFN-gamma production by Th1-type CD4 cells. Mice deficient in Tyk2 function have been previously shown to be resistant to autoimmune arthritis and septic shock but are acutely susceptible to opportunistic pathogens such as Toxoplasma gondii. In this study, we show that Tyk2, in addition to mediating the biological effects of IL-12 and IFN-alpha beta, is an important regulator for the signaling and expression of the immunosuppressive cytokine IL-10. In the absence of Tyk2, Ag-reactive CD4 cells exhibit impaired IL-10 synthesis following rechallenge of T. gondii vaccine-primed mice. The impaired IL-10 reactivation leads to unopposed antimicrobial effector mechanisms which results in a paradoxically superior protection of immune Tyk2(-/-) mice against virulent T. gondii challenge. We further demonstrate that Tyk2 indirectly controls CD4 IL-10 reactivation by signaling for maximal IFN-gamma secretion. The unexpected role of IFN-gamma in mediating IL-10 reactivation by Th1 cells provides compelling evidence that conditions driving Th1 responses establish a negative feedback loop, which will ultimately lead to its autoregulation. Thus, Tyk2 can be viewed as a dual-function Jak, mediating both pro and anti-inflammatory cytokine responses.
引用
收藏
页码:7263 / 7271
页数:9
相关论文
共 37 条
  • [1] STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES
    ABRAMS, JS
    RONCAROLO, MG
    YSSEL, H
    ANDERSSON, U
    GLEICH, GJ
    SILVER, JE
    [J]. IMMUNOLOGICAL REVIEWS, 1992, 127 : 5 - 24
  • [2] ADAMS LB, 1990, J IMMUNOL, V144, P2725
  • [3] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [4] The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure
    Belkaid, Y
    Hoffmann, KF
    Mendez, S
    Kamhawi, S
    Udey, MC
    Wynn, TA
    Sacks, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) : 1497 - 1506
  • [5] The human model: A genetic dissection of immunity to infection in natural conditions
    Casanova, JL
    Abel, L
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (01) : 55 - 66
  • [6] De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii
    Fox, BA
    Bzik, DJ
    [J]. NATURE, 2002, 415 (6874) : 926 - 929
  • [7] GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792
  • [8] Gazzinelli RT, 1996, J IMMUNOL, V157, P798
  • [9] CD4+ T cell clones producing both interferon-γ and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients
    Gerosa, F
    Nisii, C
    Righetti, S
    Micciolo, R
    Marchesini, M
    Cazzadori, A
    Trinchieri, G
    [J]. CLINICAL IMMUNOLOGY, 1999, 92 (03) : 224 - 234
  • [10] Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10
    Gerosa, F
    Paganin, C
    Peritt, D
    Paiola, F
    Scupoli, MT
    AsteAmezaga, M
    Frank, I
    Trinchieri, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) : 2559 - 2569